Showing results (31-40 of 71) with videos related to
Sort By:
Pageof 8
Molecular Cancer Research : MCR|March 3, 2023
JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast CancerBianca Cioni, Silvia Ratti, Annamaria Piva, et al.Cancer Research|November 1, 2022
ATF3 Reprograms the Bone Marrow Niche in Response to Early Breast Cancer TransformationMilena Perrone, Claudia Chiodoni, Mara Lecchi, et al.Cell Death and Differentiation|April 21, 2018
cIAP1 regulates the EGFR/Snai2 axis in triple-negative breast cancer cellsMaria Teresa Majorini, Giacomo Manenti, Miguel Mano, et al.Oncoimmunology|August 2, 2014
Stromal niche communalities underscore the contribution of the matricellular protein SPARC to B-cell development and lymphoid malignanciesSabina Sangaletti, Claudio Tripodo, Paola Portararo, et al.Neoplasia (New York, N.Y.)|December 16, 2014
Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activityGiovanna Ferrari-Amorotti, Claudia Chiodoni, Fei Shen, et al.Cell Reports|September 30, 2016
Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell ActivitySabina Sangaletti, Claudio Tripodo, Alessandra Santangelo, et al.Stem Cells (Dayton, Ohio)|August 16, 2005
Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cellsMichela Aluigi, Miriam Fogli, Antonio Curti, et al.Molecular Cancer Therapeutics|December 17, 2016
Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial-Stromal Tumors by Targeting PDGFR-βElena Jachetti, Alice Rigoni, Lucia Bongiovanni, et al.The Journal of Experimental Medicine|August 21, 2002
Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibodyAlain P Vicari, Claudia Chiodoni, Céline Vaure, et al.Expert Review of Anticancer Therapy|February 21, 2023
Overview of the synergistic use of radiotherapy and immunotherapy in cancer treatment: current challenges and scopes of improvementRiccardo Ray Colciago, Irene Fischetti, Carlotta Giandini, et al.Pageof 8